ENTRAIN VISION | European Network for integrated TRAINing on Innovative Therapies for VISion RestoratiON

Summary
Blindness is the most feared handicap leading to the greatest exclusion from society by reducing patient autonomy and mobility. There are still an estimated 39 million blind people worldwide. Clinical trials have demonstrated the possibility to regain some useful vision with retinal prostheses in patients having lost photoreceptors. New approaches are entering into clinical trials such as photovoltaic implants, optogenetic therapy and even cortical prostheses for patients having lost eye to brain connection.
In the present ENTRAIN-Vision project, the Early Stage Researchers (ESRs) will work on these innovative technologies for restoring vision in blind patients. Their training in academic institutes or industry will be completed by several secondments, including one at an industry partner. In addition, several winter/summer schools will address scientific subjects on vision restoration and transferable skills in technology transfer, clinical trials, start-up creation, communication to media. Lectures will be followed by practice e.g. innovative technologies for assessing brain function.
The project will thus create a unique European network of researchers, clinicians and industrials on visual restoration. This network will provide a comprehensive training across multiple disciplines including neuroscience, vision, psychophysics, genetic, electronic, bio-engineering and computational modelling. It will therefore prepare a new generation of leaders able to carry the new therapeutic strategies from bench to patients. ESRs will encounter founders of start-up and industrial partners enlarging thereby job opportunities to 1) remain in the career path of research & innovation, 2) contribute to clinical trials and/or develop the rehabilitation programs or 3) get involved in product manufacture, distribution and marketing throughout Europe. This project will generate great social and economic benefits in Europe by improving patient autonomy and daily life.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/861423
Start date: 01-04-2020
End date: 30-09-2024
Total budget - Public funding: 3 883 755,34 Euro - 3 883 755,00 Euro
Cordis data

Original description

Blindness is the most feared handicap leading to the greatest exclusion from society by reducing patient autonomy and mobility. There are still an estimated 39 million blind people worldwide. Clinical trials have demonstrated the possibility to regain some useful vision with retinal prostheses in patients having lost photoreceptors. New approaches are entering into clinical trials such as photovoltaic implants, optogenetic therapy and even cortical prostheses for patients having lost eye to brain connection.
In the present ENTRAIN-Vision project, the Early Stage Researchers (ESRs) will work on these innovative technologies for restoring vision in blind patients. Their training in academic institutes or industry will be completed by several secondments, including one at an industry partner. In addition, several winter/summer schools will address scientific subjects on vision restoration and transferable skills in technology transfer, clinical trials, start-up creation, communication to media. Lectures will be followed by practice e.g. innovative technologies for assessing brain function.
The project will thus create a unique European network of researchers, clinicians and industrials on visual restoration. This network will provide a comprehensive training across multiple disciplines including neuroscience, vision, psychophysics, genetic, electronic, bio-engineering and computational modelling. It will therefore prepare a new generation of leaders able to carry the new therapeutic strategies from bench to patients. ESRs will encounter founders of start-up and industrial partners enlarging thereby job opportunities to 1) remain in the career path of research & innovation, 2) contribute to clinical trials and/or develop the rehabilitation programs or 3) get involved in product manufacture, distribution and marketing throughout Europe. This project will generate great social and economic benefits in Europe by improving patient autonomy and daily life.

Status

SIGNED

Call topic

MSCA-ITN-2019

Update Date

28-04-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.1. EXCELLENT SCIENCE
H2020-EU.1.3. EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions (MSCA)
H2020-EU.1.3.1. Fostering new skills by means of excellent initial training of researchers
H2020-MSCA-ITN-2019
MSCA-ITN-2019